THE USE OF EMICIZUMAB IN A CHILD WITH HEMOPHILIA A INHIBITORY FOREMA
Hemophilia is a disease caused by hereditary deficiency of plasma coagulation factors VIII (FVIII) (hemophilia A) or IX (FIX) (hemophilia B) and characterized by hematomic bleeding. The main therapeutic measures in patients with hemophilia are aimed at replacing the deficient factor both during hem...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
The Publishing House Medicine and Enlightenment
2023-02-01
|
Series: | Мать и дитя в Кузбассе |
Subjects: | |
Online Access: | https://mednauki.ru/index.php/MD/article/view/843 |